Drug Database
Back to search

Poland· PL-100441882

Idefirix

A imlifidase product containing imlifidasum, registered in Poland by Hansa Biopharma AB. The same ATC class is registered in 12 of our 19 countries.

ATC L04AA41

Checked against URPL (Poland) on

Informational only — not a medical device.

SOURCE REGISTER · PLURPL (Poland)normalisedIdefirixATCL04AA41REGISTER NO.PL-100441882PACKS LISTED2CHECKEDSeptember 27, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about imlifidasumAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Imlifidase is registered in 12 of 19 countries.

Countries holding a registration under ATC L04AA41 (imlifidase), each read from that country’s own register.

  • This record: Poland, from URPL (Poland)
  • 8 of them publish a price we can compare per daily dose
Search imlifidase products by name

Imlifidase · ATC L04AA41

12 / 19 countries

  • Belgiumprice
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Franceprice
  • Icelandprice
  • Ireland
  • Netherlands
  • Norwayprice
  • Polandprice
  • Switzerlandprice
  • United Kingdom
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of imlifidase costs, country by country.

Normalised to the WHO defined daily dose (17.5 mg), so markets compare like for like.

  • 1 market with a comparable price for this class
  • Public list prices, converted to USD at the rate date shown
Open the full comparison — free accountDrug prices for market access

Imlifidase · price per daily dose (17.5 mg)

USD · FX 28 Sept 2026

  • CH Switzerland$271803.14
Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

URPL (Poland)
Active substance
Imlifidasum
Manufacturer
Hansa Biopharma AB
Country
Poland (PL)
ATC code
L04AA41
ATC class
Imlifidase
Defined daily dose
17.5 mg, P
Reimbursed
Not published by this register
Source register
URPL (Poland)
Last checked
September 27, 2026

Packs & prices · 2

  • gtin
    07350118290033
  • gtin
    07350118290040

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Imlifidase in 12 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All imlifidase products

Authorised across Europe · EMA

The same active substance is authorised in 3 EEA countries. Names it is sold under:

  • Iceland · Idefirix
  • Liechtenstein · Idefirix
  • Norway · Idefirix

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/f8c3d71d-289a-4544-a93c-bc9c98292dd1
GET /v1/drugs/f8c3d71d-289a-4544-a93c-bc9c98292dd1?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Proszek do sporządzania koncentratu roztworu do infuzji",
  "source": "urpl",
  "strength": "11 mg",
  "packaging": "Rpz ¦ EU/1/20/1471/001 ¦ 137786\n1 fiol.  proszku\n¦ UR/Z/4b/056/22 - 07350118290033 ¦ UR/Z/4b/020/23 - 07350118290033 ¦ UR/Z/4b/118/24 - 07350118290033 ¦ UR/Z/4b/154/23 - 07350118290033 ¦ UR/Z/4b/084/23 - 07350118290033 ¦ UR/Z/4b/089/22 - 07350118290033 ¦ UR/Z/4b/038/25 - 07350118290033 ¦ UR/Z/4b/159/25 - 07350118290033 ¦ UR/Z/4b/126/26 - 07350118290033\nRpz ¦ EU/1/20/1471/002 ¦ 137787\n2 fiol.  proszku\n¦ UR/Z/4b/085/23 - 07350118290040 ¦ UR/Z/4b/155/23 - 07350118290040 ¦ UR/Z/4b/057/22 - 07350118290040 ¦ UR/Z/4b/021/23 - 07350118290040 ¦ UR/Z/4b/119/24 - 07350118290040 ¦ UR/Z/4b/095/22 - 07350118290040 ¦ UR/Z/4b/039/25 - 07350118290040 ¦ UR/Z/4b/160/25 - 07350118290040 ¦ UR/Z/4b/127/26 - 07350118290040",
  "substance": "Imlifidasum 11 mg",
  "common_name": "Imlifidasum",
  "pl_product_id": "100441882",
  "pozwolenie_nr": null,
  "auth_procedure": "CEN",
  "authorisation_validity": null
}
API referenceMCP serverPlans

See everything about imlifidase.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console